Estee Lauder Companies Inc (EL) Stock Price Today
Key Stats
- $30.26BMarket Cap
- -Volume
- Consumer StaplesSector
- $119.6152W High
- $67.2352W Low
- -Typical Hold Time
- $36.43BEnterprise Value
- 1.67%Div Yield
- -Trading Activity
Track Estee Lauder Companies Inc (EL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Estee Lauder Companies Inc has traded between a low of $67.23 and a high of $119.61, highlighting its annual price range. Buy and sell Estee Lauder Companies Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Most Recent News
City Holding Co director buys 110 shares amid 11.27% YTD stock gain and steady dividends.
A director of City Holding Co increased their stake by purchasing 110 shares at $134.55 each, signaling confidence in the company. The stock has risen 11.27% year-to-date and is trading near its 52-week high, reflecting strong market performance. Cit...
Chubb posts strong Q2 profit growth despite missing revenue targets, boosts dividends and share buyback.
Chubb Limited reported Q2 core operating earnings per share of $7.26, beating estimates and marking an 18.2% increase year-over-year. However, consolidated net premiums written were $14.7 billion, below the expected $15.07 billion, though key segment...
Global AI in drug repurposing market to hit $10.56B by 2035, growing at 23.4% CAGR
The global AI in drug repurposing market, valued at $1.28 billion in 2025, is projected to reach $10.56 billion by 2035 with a CAGR of 23.4%. This growth is driven by the need to accelerate drug discovery, reduce costs, and address chronic and rare d...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.